This platform is currently totally free and created by doctors. 🩺

RxIndia

Loading clinical data...

The most trusted clinical drug reference for Indian healthcare professionals. Providing evidence-based monographs, dosage protocols, and expert guidelines to empower better clinical decisions.

Resources

Full Drug Index
Clinical Guidelines
Classifications
Specialties

Weekly Updates

Stay updated with the latest FDA approvals, drug alerts, and clinical practices.

Verified Clinical Information

"This platform is a clinical reference tool for educational purposes only. It is not a substitute for professional medical judgment, diagnosis, or treatment. Always seek the advice of a qualified physician."

A Medical Intelligence Initiative

About Contact Privacy Terms

Developeredonesolutions

HomeDrug Index

The Drug Registry

Found 4 drugs.

Atazanavir

Protease Inhibitor (PI)

1. Always use ritonavir boosting: Unboosted atazanavir leads to subtherapeutic levels, especially when coadministered with tenofovir — ritonavir 100 m...

View Details

Dolutegravir

Integrase Strand Transfer Inhibitor (INSTI)

Preferred firstline ART in India per NACO 2021 — TLD (Tenofovir + Lamivudine + Dolutegravir) is the recommended singletablet regimen for treatmentnaïv...

View Details

Efavirenz

Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)

Bedtime dosing on empty stomach is key to minimising CNS side effects — counsel patients that dizziness and vivid dreams usually resolve within 2–4 we...

View Details

Nevirapine

Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)

Leadin phase is nonnegotiable: Always initiate with 200 mg once daily for 14 days to reduce incidence and severity of rash and hepatotoxicity. Never s...

View Details

All 4 drugs shown